The acute effect of a single application of cabergoline on endogenous GH levels in patients with acromegaly on pegvisomant treatment
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference39 articles.
1. Pegvisomant interference in GH assays results in underestimation of GH levels;Paisley;Eur. J. Endocrinol.,2007
2. Growth hormone (GH) receptor blockade with a PEG-modified GH (B2036-PEG) lowers serum insulin-like growth factor-I but does not acutely stimulate serum GH;Thorner;J. Clin. Endocrinol. Metab.,1999
3. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly;Kopchick;Endocr. Rev.,2002
4. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist;van der Lely;Lancet,2001
5. Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study;Schreiber;Eur. J. Endocrinol.,2007
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management;Nature Reviews Endocrinology;2024-06-06
2. Secondary diabetes mellitus in acromegaly;Endocrine;2023-03-08
3. Drug treatment strategies for secondary diabetes in patients with acromegaly;Expert Opinion on Pharmacotherapy;2020-07-07
4. Dopamine Agonists for Pituitary Adenomas;Frontiers in Endocrinology;2018-08-21
5. Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegaly;Expert Review of Endocrinology & Metabolism;2016-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3